Paul S. Herendeen

Overview

Paul S. Herendeen received an average of $13M in total compensation, including $782K in salary, at Valeant Pharmaceuticals International from 2016 to 2018. Paul Herendeen also received an average of $2M at Zoetis from 2014 to 2016.

Source: SEC filings on March 18, 2019, March 21, 2018, and March 31, 2017.

Related executives

We found 31 more executives who work or worked at Valeant Pharmaceuticals International and Zoetis.

Joseph Papa

Valeant Pharmaceuticals International

Chief Executive Officer

Juan Alaix

Zoetis

Chief Executive Officer

Clinton Lewis

Zoetis

Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics and Aquatic Health

Thomas Appio

Valeant Pharmaceuticals International

President & Co, Head, Bausch + Lomb/International

Christina Ackermann

Valeant Pharmaceuticals International

General Counsel

Kristin Peck

Zoetis

Executive Vice President and Group President, U.S Operations, Business Development and Strategy

Glenn David

Zoetis

Chief Financial Officer

Catherine Knupp

Zoetis

Executive Vice President and President of Research and Development

News

You may also like